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ABSTRACT 
 
Part I.  Self-immolative linkers are dynamic molecules which connect a cleavable mask 
to an output cargo molecule. Upon an input reaction that cleaves the mask, the self-immolative 
linker releases the output cargo.  The scope of my research is synthesis of a new class of self-
immolative linkers—aryl phthalate esters–sensitive to various inputs and able to release various 
cargo molecules, including within S2 cells.  
 In Chapter 1, fluoride sensitive aryl phthalate esters containing a phenolic output cargo 
molecule were synthesized.  The fluoride sensitive 2-(trimethylsilyl)ethyl ether group was used as 
the mask molecule for each ester. The output cargo molecules were phenol, 7-hydroxycoumarin, 
and 3-(2-benzothiazolyl)-7-hydroxycoumarin.  Full release of the cargo molecules were followed 
by NMR and fluorescence spectroscopy.  The 7-hydroxycoumarin containing phthalate ester 
showed a 730-fold increase in fluorescence upon complete fluoride deprotection, making these 
compounds potential fluoride sensors.  
In Chapter 2, self-immolative aryl phthalate esters conjugated with cleavable masking 
groups sensitive to light and hydrogen peroxide are reported. By altering the masking group, the 
phthalate linker releases the fluorescent dye 7-hydroxycoumarin upon exposure to stimuli such as 
light or hydrogen peroxide, respectively, leading to an increase in fluorescence. The light-sensitive 
aryl phthalate ester is demonstrated as a pro-fluorophore in cultured S2 cells. 
 Part II.  BODIPY dyes can be meso-substituted to provide a new class of photoremovable 
protecting groups (PPGs).  A PPG is the term used to describe a moiety (also known as a 
photocage) that has a deactivating influence on the biological substrate to which it is covalently 
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attached.  Once the covalent bond is broken, the substrate is released and its reactivity or function 
is regained.  Ideally, the cage detaches only through the action of light, giving investigators precise 
temporal and spatial control. 
In Chapter 3, photoremovable protecting groups derived from meso-substituted BODIPY 
dyes release acetic acid with green wavelengths >500 nm, and photorelease is demonstrated in 
cultured S2 cells.  The photocaging structures were identified by our lab’s previously proposed 
strategy of computationally searching for carbocations with low-energy diradical states as a 
potential indicator of a nearby conical intersection.  The superior optical properties of these 
photocages make them promising alternatives to the popular o-nitrobenzyl photocage systems. 
In Chapter 4, a meso-substituted BODIPY photoremovable protecting group from Chapter 
3 has been red-shifted by extending the conjugation of the BODIPY structure using a Knoevenagel 
condensation reaction.  Release of acetic acid from the BODIPY photocage is successful using 
>600 nm light, making these photocages promising for use in photorelease studies in whole tissues 
or animals.  
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INTRODUCTION FOR PART I 
 
SELF-IMMOLATIVE LINKERS 
More than a century ago, Paul Ehrlich, a German immunologist and the founder of 
chemotherapy, established his “magic bullet” ideology.1 Ehrlich reasoned that if a compound could 
be constructed to selectively target a diseased area of an organism, then a toxin for the disease 
could be delivered along with the targeting molecule and kill the disease.1  A more modern and 
widely used term for this type of system is “pro-drug”.  A pro-drug is a medication that is 
administered in an inactive form, and is then converted to its active form through a bond cleavage 
event using a stimulus such as an enzyme.2  
 
 
Figure 1. Un-masking and drug release of pro-drug 
 
The concept of starting with an inactive molecule and activating it using a specific stimulus 
has received much attention from the scientific community.  In the midst of developing a “magic 
bullet,” many other avenues of research have spawned, including the development of pro-
fluorophores, molecular probes, degradable polymers, and chemical sensors. 
 
Self-immolative Linkers. One potential way to allow targeted drug delivery is through the use of 
self-immolative linkers.  Conceptually, connecting a cargo molecule directly to the masking 
molecule (as shown in Fig. 1) can result in switching off bioactivity.  A self-immolative linker can 
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then be used to help aid in stability, solubility, biodistribution, pharmacokinetics, bioavailability 
and disease-targeted activation.  Such self-immolative linkers are also highly useful in the design 
of chemical sensors, wherein a reporter molecule is released upon a mask-cleaving reaction by an 
analyte. 
A self-immolative linker is a molecule that attaches a cleavable masking molecule to an 
output cargo molecule.  Upon introduction of the specific stimulus, the mask-linker bond is broken, 
and, in turn, the linker-cargo bond is broken. Typical input stimuli can include enzymatic activity, 
chemical cleavage, irradiation, or change in pH.  Typical cargo molecules are drugs, reporter 
molecules, dyes, or other biomolecules.   
 
 
 
 
 
 
Figure 2. Un-masking and cargo release of self-immolative linker 
 
Quinone Methide. The most common type of self-immolative linker to date is para-aminobenzyl 
alcohol (PABA), most recently championed by the lab of Shabat.  This type of linker is able to 
undergo both 1,4 and 1,6 elimination via a quinone methide intermediate.3 In the presence of water 
or a nucleophile, the quinone methide is quickly restored back to an aryl amine (see Figure 3). 3 
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Figure 3. Quinone methide cargo release mechanism of PABA 
 
Commonly an ester linkage between the self-immolative linker and the cargo molecule is 
used, releasing CO2 and helping to drive the reaction forward.
3   
 
Figure 4. Use of ester linkage helps drive the release of cargo forward 
 
The PABA linker was first introduced as a delivery system by Carl 4 in 1981 where an N-
Boc-Lys group was used as the mask, trypsin was the input stimulus, and para nitroaniline was the 
cargo molecule.  Carl was also the first to propose the term “self-immolative connector” to describe 
a connector linkage of this type.   
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Figure 5. Initial PABA-based self-immolative linker 
 
The system was found to be fairly stable in water at pH 6.9 in the absence of trypsin with 
a half-life of 40 hours at 25 ᵒC.  Under the same conditions, but in the presence of trypsin the half-
life decreased to 11 minutes.  Since the introduction of PABA, chemists utilized it to deliver drugs, 
fluorescent dyes, and biomolecules.  
Senter, et. al.5 reported the development of a prodrug strategy based on the reactivity of 
benzyl carbamate disulfide drug derivatives toward mild reducing agents. Upon disulfide bond 
reduction, appropriately substituted benzyl carbamates were shown to undergo fragmentation, and 
the amine-containing element of the carbamate was released. Mitomycin C, a chemotherapy drug, 
was used as one of the amine-containing elements. 
 
 
Figure 6. Disulfide bond reduction leads to the release of the chemotherapy drug Mitomycin C 
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De Groot et. al.6 developed a system to release anthracyclines (doxorubicin and 
daunorubicin).  Release occurred in the presence of the tumor-associated serine protease plasmin.  
A similar prodrug was synthesized which did not contain the self-immolative linker; however, 
inefficient drug release was observed.  It was thought that attaching the drug directly to the tri-
peptide caused too much steric bulk and the enzyme was not able to effectively access the tri-
peptide.7 This is a prime example of the benefit of having a self-immolative linker in a cargo 
release system. 
 
Figure 7. A serine protease plasmin sensitive prodrug 
 
De Groot’s lab8  used a quinone-methide elimination in an extended conjugated 1,8 fashion 
to demonstrate a bioreductive paclitaxel prodrug. The 1,8-linker showed better stability towards 
enzymatic hydrolysis than its 1,4 analogue making it a more viable option for a prodrug.  The 
researchers also attempted to use a naphthalene and biphenyl spacer system to undergo a 1,8 and 
1,10 elimination, respectively.  However, the desired eliminations were not observed.9 
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Figure 8. Bioreduction of an aryl nitro group yields active Paclitaxel 
 
 
 
 
Figure 9. Use of naphthalene and biphenyl spacers did not result in elimination of cargo 
 
Springer, et al.10 designed four potential self-immolative prodrugs derived from phenol and 
aniline nitrogen mustards, all activated by the enzyme carboxypeptidase (CPG2).  The analogue 
shown in Fig. 10 was found to be the most promising prodrug of the series.  Nitrogen mustards 
form cyclic aziridinium ions by intramolecular displacement of the chlorine by the amine nitrogen.  
The aziridinium group alkylates DNA once it is attacked by a base pair of DNA.11  This type of 
trauma leads to cell apoptosis.11  The half-life for this particular pro-drug at a concentration of 10 
mM in DMSO is 48 minutes in the absence of carboxypeptidase G2 (CPG2) and 7.6 minutes in 
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the presence of CPG2.  The IC50 for this compound was found to be 0.46 µM.  (The IC50 is the 
amount of a particular drug that is needed to inhibit a certain biological response by half.) 
 
 
Figure 10. Nitrogen mustard prodrug 
 
Papot, Renoux, et. al.12 introduced a glucuronide prodrug of cyclopamine designed to 
selectively target the Hedgehog signaling pathway of cancer cells.  The prodrug included a self-
immolative linker containing a hydrophilic side chain that can be easily introduced via “click 
chemistry”.  In the prescence of β-glucuronidase, the prodrug exhibited quick release of 
cyclopamine and antiproliferative activity in U87 glioblastoma cells.   
 
Figure 11. Cyclopamine prodrug; R= hydrophilic side chain 
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An amplifying effect of the above linker shown in Fig. 11 was achieved using both 1,6 
and 1,4 elimination of a PABA linker.13  The system is composed of five units including a 
targeting ligand for folate receptor positive tumor cells, an enzymatic trigger sensitive to β-
galactosidase, a self-immolative linker and two doxorubicin compounds expressed around a 
chemical amplifier.  The assembly is able to recognize a selected population of cells, penetrate 
into the intracellular medium through endocytosis and transform a single enzymatic activation 
into the release of two active drugs.  Papot’s self-immolative linker units are PABA derivatives 
which contain a nitro group in the ortho position of the aromatic ring.  The strategic positioning 
of this strongly electron withdrawing group allows for faster kinetics of cargo release.14 
 
    
 
 
 
 
 
 
 
 
Figure 12. Self-immolative doxorubicin amplifier 
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Shabat, et al. has done extensive work using PABA to release multiple cargo molecules for 
a single triggering event. He has coined the term “self-immolative dendrimers” for these systems.  
The unique structural dendrimers can release all of their tail units, through a self-immolative chain 
fragmentation, which is initiated by a single cleavage at the dendrimer’s core.15  First generation 
dendritic prodrugs released doxorubicin and camptothecin as tail units and a retro-aldol retro-
Michael focal trigger, which can be cleaved by catalytic antibody 38C2.16  With these systems, a 
single cleavage event leads to the release of multiple cargo molecules. 
 
 
Figure 13. Shabat’s first-generation dendridic prodrug 
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Shabat’s group has since developed systems which can release three17 and six18 cargo 
molecules for every cleavage event at the dendrimer’s core.  The effect of swapping a benzene 
ring for a pyridine ring in the dendrimer’s core has also been studied.19  Shabat20 has also  
introduced a molecular design for a theranostic prodrug based on a self-immolative linker attached 
to a pair of FRET dyes that produce a fluorescent signal upon disassembly.  
 
 
Figure 14. Self-immolative system containing FRET dyes 
 
A turn-ON fluorescent diagnostic signal accompanies the disassembly of the prodrug and 
allows for monitoring of active drug release.  The drug used in this system was camptothecin and 
activation was by the enzyme PGA.  They found good correlation between the emitted 
fluorescence and the amount of free drug released. 
McCarley et. al.21 has more recently shown a cloaked ﬂuorophore self-immolative linker 
system composed of a reporter molecule, naphthalimide, whose ﬂuorescence is eﬃciently 
quenched by it being bound to a “trimethyl lock” trigger group through a PABA based, N-methyl-
p-aminobenzyl alcohol, self immolative linker. Activation of the trigger group was achieved by 
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chemical and enzymatic means which ulitimately resulted in release of naphthalimide and an 
intense red-shifted emission.  
 
Figure 15. Release of the fluorescent dye naphthalimide (λmax= 540 nm) through enzymatic or 
chemical reduction of a “trimethyl lock”22 precursor 
 
Romieu et. al.23 used PABA as a key component in the design of a protease-sensitive 
fluorgenic probe whose parent coumarin fluorophore is released in the presence of penicillin 
amidase and caspase-3 protease.  
 
 
Figure 16. A protease-sensitive fluorgenic probe 
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A self-immolative dendritic probe which detects triacetone triperoxide through 
amplification of a single cleavage event initated by one molecule of hydrogen peroxide into 
multiple release of fluorogenic end-groups was introduced by Shabat’s group.24   
 
Figure 17.  A self-immolative dendritic probe which detects triacetone triperoxide 
 
Trimethyl Lock. Aside from the PABA-based self-immolative linkers, self-immolative linkers 
which undergo cyclization reactions in order to release a cargo molecule are popular.  One example 
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is the “trimethyl lock quinone” which undergoes an intramolecular lactonization and leads to the 
release of a cargo molecule.  The trimethyl lock is an o-hydroxy-cinnamic acid derivative in which 
unfavorable interactions between three methyl groups encourage rapid lactonization.22 
 
Figure 18. Tri-methyl lock 
 
The inspiration for the tri-methyl lock came from Cohen and co-workers from the National 
Institute of Health in the 1960s.25  They developed a model to test whether ubihydroquinone, which 
was suspected to be a key cofactor in the electron-transport chain, could be esterified by protein 
carboxylates to produce a high energy intermediate upon oxidation. The high energy intermediate 
would be able to activate inorganic phosphate to form a phosphoanhydride.  Phosphoanhydrides 
transfer a phosphoryl group to adenosine 5’-diphosphate (ADP), generating ATP. 22 
Ronald Borchardt et. al.22 introduced the “trimethyl lock” as a bioreversible option for 
release of an amine.  In general, amides hydrolyze too slowly to be useful as prodrugs. However, 
Borchardt used the trimethyl lock to mask amines.  The utility is apparent in the acetyl ester of the 
trimethyl lock, which releases p-methoxyaniline upon ester hydrolysis. 
 
 
Figure 19. Circumventing sluggish amide hydrolysis with trimethyl lock  
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Borchardt, Nicoleu, et. al.22 used the trimethyl lock to increase the water solubility of the 
otherwise insoluble Paclitaxel chemotherapy drug.  It was found that the trimethyl lock analogue’s 
solubility in water was >10mg mL-1 at 37 degrees Celsius, compared to Paclitaxel with is about 
2mg mL-1 in water at 37 degrees Celsius.   
Ronald Rains has done extensive work using “trimethyl lock” to release fluorescent 
molecules.  The example in Fig. 18 used “trimethyl lock” as a fluorogenic probe for esterase.22   
 
 
Figure 20. An esterase-sensitive fluorogenic probe 
 
In this example, rhodamine 110 is conjugated to two trimethyl lock moieties through amide 
linkages rendering it virtually non-fluorescent.  However, in the presence of esterase, hydrolysis 
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of the acetate groups leads to cyclization of the trimethyl locks and release of the rhodamine 110 
fluorescent dye.  Anilino fluorphores, in contrast to their hydroxy analogues, are not as prone to 
hydrolysis and their fluorescence intensity is not dependent on pH.26  However, because they 
contain an amide, hydrolysis is slow.  Adding the tri-methyl lock allows for faster ester hydrolysis 
followed by the release of a highly-fluorescent dye which is not dependent on pH.      
Self-immolative linkers have also been incorporated into polymer systems. Greenwald et. 
al.27 synthesized various poly(ethylene glycol) prodrugs of amino-containing compounds 
containing drugs such as  Danorubicin.  The addition of the PEG spacer aids in solubilization of 
insoluble drugs, extending plasma circulating half-lives and, in the case of anticancer agents, 
apparent tumor accumulation.28 
 
Figure 21. Polymeric self-immolative linker system 
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Zhou et. al.29 recently synthesized a highly sensitive self-cleavable trimethyl lock quinone-
luciferin substrates for diaphorase designed to measure NAD(P)H in biological samples.  Quinones 
are known substrates for oxidoreductases and were reduced by accepting two electrons from 
NAD(P)H in a reactions catalyzed by diaphorase.29  Upon reduction of the quinone the release of 
the biololuminescent luciferin molecule was observed using a luciferin detection reagent and a 
luminometer.  Zhou reports that this bioluminescent assay provides advantages over current 
methods that quantify NAD(P)/NAD(P)H in biological samples because these other methods 
involve complicated preparation techniques.   
 
 
Figure 23. An NAD(P)H detector 
 
Other Cyclization Mechanisms. Ojima et. al.30 made a tumor-targeting drug delivery system 
using a tumor-targeting molecule (biotin: vitamin H or vitamin B-7), a mechanism based self-
immolative linker and a taxoid (SB-T-1214) as the cytoxic agent. 
17 
 
 
 
 
Figure 24. Use of a tumor targeting module (TTM) allows for selective release of taxoid  
 
De Groot et. al.8 synthesized analogous paclitaxel prodrugs one with a quinone methide 
linker and one with a cyclization linker. It was found that using the quinone methide linker led to 
a less cytotoxic pro-drug. Activation for the prodrugs was achieved using the tumor-associated 
enzyme plasmin. 
 
 
Figure 25. Analogous quinone methide based linker and cyclization linker prodrugs 
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Many of the currently utilized self-immolative linkers suffer from slow kinetics and solubility 
issues.  It would be very beneficial if there were a self-immolative linker which possesses the 
following traits: 
1. Kinetics which are on the time scale of the biological event being probed or desired time 
frame of drug delivery 
2. Stable to conditions which do not include the input stimulus 
3. Straight-forward synthesis with few steps 
4. Once the linker has performed function, its byproduct should be benign  
5. Inexpensive to synthesize 
6. Aqueous compatibility for biological application 
The following chapters describe the use of a new and promising class of self-immolative linker 
based on phenyl ester phthalate. 
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CHAPTER 1 
 
SELF-IMMOLATIVE ARYL PHTHALATE ESTERS 
 
Taken in part from: Mahoney, K. M.; Goswami, P. P.; Winter, A. H., J. Org. Chem., 2013, 78, 
702. 
  
Introduction 
  Self-immolative linkers have become indispensible molecules for connecting a cleavable 
mask to an output cargo molecule.1−3 Upon an input reaction that cleaves the mask, self-immolative 
linkers release their output cargo. Despite their unsavory moniker, self-immolative linkers have 
proven to be extremely useful in enzyme-activated prodrugs,4−12 chemical sensors,2,13−16 traceless 
linkers,17−20 biological probes,21−24 and degradable polymers.1,25−33 Released chemical cargoes are 
often biomolecules, drugs, or reporters such as fluorescent dyes. Linker structure can aid prodrugs 
by improving stability, solubility, biodistribution, pharmacokinetics, bioavailability and 
activation. 
The ideal self-immolative linker does not impose: It is simple, stable, compatible with 
water, and transforms into a benign byproduct upon releasing the output cargo. Furthermore, such 
linkers should be easy to conjugate, readily adaptable to a variety of inputs and outputs, and quickly 
release the output cargo upon the input reaction. In particular, some common self-immolative 
linkers suffer from slow release of their output cargo. New linkers that incorporate these desirable 
features would be highly useful. 
The hydrolysis of phenyl hydrogen phthalate is a classic case of neighboring group 
participation, the mechanism of which has seen extensive investigation.34−37 Phenyl hydrogen 
phthalate is a shelf-stable compound when stored away from moisture, but this compound 
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hydrolyzes rapidly in water (Scheme 1). It has been determined that the fast ester hydrolysis of 
this compound is a case of intramolecular catalysis wherein the neighboring carboxylate group 
displaces the phenol to generate a water-unstable anhydride that in turn spontaneously hydrolyzes 
to phthalic acid. In neutral water, release of phenol is too fast to obtain accurate rate constants 
using standard UV−vis studies (τ < 5 s), but the rate of release is slowed in more acidic water (τ = 
23 s, pH 5.7). The known favorable kinetics of this hydrolysis led us to test aryl phthalate esters 
for use as self-immolative linkers. 
 
 
 
 
 
 
 
Scheme 1. Fast hydrolysis of the classic phenyl hydrogen phthalate hydrolysis in water followed 
by monitoring growth and decay of phthalic anhydride 
 
Incorporating a classic reaction into a self-immolative linker.  The hydrolysis of phenyl 
hydrogen phthalate is a classic case of neighboring group participation. 31-34 Phenyl hydrogen 
phthalate is a shelf-stable compound when stored away from moisture, but this compound 
hydrolyzes rapidly in water (Scheme 1).  The astounishingly fast ester hydrolysis of this compound 
is an exemplary case of intramolecular catalysis wherein the neighboring carboxylate group 
displaces the phenol to generate a water-unstable anhydride that in turn spontaneously hydrolyzes 
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to phthalic acid.   In neutral water, release of phenol is too fast to obtain reliable rate constants 
using standard UV-Vis studies (t < 5 sec), but the rate of release is slowed in more acidic water (t 
= 23 sec, pH 5.7).  The favorable kinetics of this hydrolysis led us to test aryl phthalate esters for 
use as self-immolative linkers.    
Using a fluoride-sensitive 2-(trimethylsilyl)ethyl ether to mask the catalytic carboxyl 
group, in combination with three phenolic cargos (phenol 1 plus the fluorescent dyes 7-
hydroxycoumarin 2 and 3-(2-Benzothiazolyl)-7-hydroxycoumarin 3), we find that aryl phthalate 
esters can indeed be exploited as self-immolative linkers.  We show that these linkers can be 
conjugated easily starting from phthalic anhydride, a cheap industrial starting material in the 
manufacture of plastics, and “self-immolate” to ultimately yield phthalic acid as a biologically 
benign byproduct upon release of the phenolic output.  
 
Results and Discussion 
 
 
Figure 1.  Aryl phthalate esters described in this study. 
 
 
Fluoride titrations studies and product analysis.   Compounds 1-3 were synthesized and 
titrated with fluoride ion (Scheme 2) in pH 7 buffer.  The titration of 1 was followed by 1H NMR 
spectroscopy and titrations of 2 and 3 were followed with fluorescence spectroscopy. The titration 
of compound 2 is remarkable because we observe a 730-fold increase in fluorescence upon 
complete fluoride deprotection as a consequence of the release of the highly fluorescent 7-
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hydroxycoumarin dye.  Thus, compound 2 is an exquisite fluoride sensor.  Curiously, compound 
3 shows a decrease in fluorescence during the titration even though the highly fluorescent free 
coumarin dye is released.  This decrease in fluorescence is due to the starting ester 3 being highly 
fluorescent, whereas ester 2 is essentially non-fluorescent.   
Chemical stability, product analysis, and release mechanism.  Compounds 1-3 are stable in 
water in the absence of fluoride, with no decomposition observed after 1 day at room temperature 
(see Supporting Information).   Additionally, NMR product analysis after fluoride deprotection 
indicates that the organic end products are the free phenolic compound and phthalic acid.  These 
results lead us to postulate the mechanism  of release shown in Scheme 2.   Surprisingly, our 
titrations indicate that compounds 2,3 require three equivalents of fluoride to achieve complete 
deprotection, while 1 requires the expected 1 eq. of fluoride.  This “excess” F- required is puzzling 
since the presumed mechanism for TMSE deprotection involves a single fluoride ion adding to the 
silicon to eliminate ethane gas and trimethylsilylfluoride.  Possibly, deprotection of 2 and 3 
proceed through a hypervalent silicon mechanism, although further work would be needed to 
verify this mechanistic possibility. 
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Figure 2.  Fluoride titrations by NMR for 1 (top) and by fluorescence detection for 2 (middle) 
and 3 in pH 7.0 buffer.  Plot inserts depict fluorescence (or NMR integration) at the emission 
maxima vs. equivalents of tetrabutyl ammonium fluoride. 
 
 
 
Scheme 2.  Putative mechanism of decomposition of 1-3 with F- ion. 
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Compounds 1-3 were prepared from phthalic anhydride (See Scheme 3).  Addition of 
TMSE to phthalic anhydride yields the TMSE-protected acid ester, which was further converted 
to aryl esters 2,3 using the Stieglich DCC/DMAP coupling procedure.  For 1, esterification of 
phenyl hydrogen phthalate was accomplished in a similar way using DCC/DMAP conditions. 
 
 
 
Scheme 3. Synthesis of 1-3. 
 
 
Experimental    
Phenyl hydrogen phthalate, 34 2-(trimethylsilyl)ethyl hydrogen phthalate, 35 and 3-(2-
benzothiazolyl)-7-hydroxycoumarin 36 were prepared by published procedures.  All NMR 
matched the known spectra.  
 
Synthesis of phenyl 2-(trimethylsilyl)ethyl phthalate 1. Phenyl hydrogen phthalate (1.50 g, 6.21 
mmol), 2-trimethylsilylethanol (1 mL, 6.98 mmol) and 4-N,N-dimethylaminopyridine (0.085 g, 
0.69 mmol) were dissolved in dry DMF (4 mL), followed by continuous stirring of the solution. 
N,N-dicyclohexylcarbodiimide (1.54g, 7.45 mmol), dissolved in dry DMF (2 mL), was next 
added to the reaction mixture and the reaction was stirred under an argon atmosphere overnight. 
The dicyclohexylurea byproduct was filtered off as a white solid. The solvent was then removed 
under reduced pressure to yield the crude product as a yellow oil. Flash chromatography 
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(Hex/EtOAc, 90:10) gave the pure final product (0.595 g, 28%) as a colorless oil. (1H NMR, 
CD3OD, 400 MHz)  7.90 (m, 1H), 7.83 (m, 1H), 7.70 (m, 2H), 7.46 (m, 2H), 7.29 (m, 3H), 
4.44-4.40 (m, 2H), 1.09 (m, 2H), 0.04 (s, 9H); (13C NMR, CD3OD, 100MHz)  169.1, 167.9, 
152.5, 133.9, 133.1, 132.9, 132.7, 130.7, 130.4, 130.2, 127.3, 122.7, 65.4, 18.3, -1.4; High-res 
MS(ESI) calculated for formula C19H23O4Si (M+1) requires 343.1287; found 343.1360. 
 
Synthesis of 7-hydroxycoumarinyl 2-(trimethylsilyl)ethyl phthalate 2.  2-(trimethylsilyl)ethyl 
hydrogen phthalate (1.29 g, 4.83 mmol), 7-hydroxycoumarin (1.21 g, 4.83 mmol), and 4-
dimethylaminopyridine (0.65 g, 5.3 mmol) were dissolved in a mixture of anhydrous methylene 
chloride (15 mL) and anhydrous DMF (9 mL).   N,N-dicyclohexylcarbodiimide was quickly 
added to the reaction mixture and stirred under argon overnight.  Dicyclohexyl urea was filtered 
off and the filtrate was diluted 10 mL of methylene chloride.  The solution was washed with 
brine and then dried over anhydrous MgSO4.  The crude product was collected by evaporation 
under reduced pressure and then purified by flash chromatography on silica gel (Hex/EtOAc, 
70:30) to yield 2 (0.65g, 33%) as a white solid: (1H NMR CDCl3, 400 MHz) δ 7.87, (m, 2H), 
7.73 (d, 1H, J = 8 Hz), 7.64 (m, 2H), 7.57 (d, 1H, J = 8 Hz), 7.34 (s, 1H), 7.30 (s, 1H),  6.43 (d, 
1H, J = 8 Hz), 4.43 (t, 2H, J = 8 Hz), 1.11 (t, 2H, J = 8 Hz), 0.06 (s, 9H); (13C NMR CDCl3, 100 
MHz) δ 167.2, 166.2, 160.7, 155.1, 153.7, 143.2, 132.0, 131.8, 131.7, 129.6, 129.4, 128.9, 118.7, 
117.2, 116.5, 110.8, 64.7, 17.7, -1.1. High-res MS (ESI) calcd. for formula C22H22O6Si (M+1) 
requires 411.1186; found, 411.1258. 
  
Synthesis of 3-(benzo[d]thiazol-2-yl)-7-hydroxycoumarinyl-2-(trimethylsilyl)ethyl phthalate 3. 
2-(trimethylsilyl)ethyl hydrogen phthalate (50 mg, 0.34 mmol), 3-(2-benzothiazolyl)-7-
hydroxycoumarin (99 mg, 0.34 mmol), and 4-dimethylaminopyridine (4 mg, 0.034 mmol) were 
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dissolved in DMF (5 mL).  N,N-dicyclohexylcarbodiimide (69 mg, 0.34 mmol) was quickly 
added to the reaction mixture and was stirred under argon for 12 h.  The white solid was filtered 
off and the DMF was removed by evaporation under reduced pressure. The crude mixture was 
purified by preparatory thin-layer chromatography (200 microns) using a (Hex/EtOAc, 70:30) 
eluent followed by an additional prep TLC purification using (Hexane/EtOAc, 50:50) to yield the 
product 3 (37 mg, 20%) as a yellow solid: (1H NMR CDCl3, 400 MHz) δ 9.11 (s, 1H), 8.12 (d, 
1H, J=8 Hz), 8.01 (d, 1H, J = 8 Hz), 7.89 (m, 2H), 7.81 (d, 1H, J = 8 Hz), 7.66 (m, 2H), 7.56 (t, 
1H, J = 8 Hz), 7.48 (s, 1H), 7.45 (s, 1H), 7.40 (dd, 2H, J = 4 Hz), 4.45 (t, 2H, J = 8 Hz), 1.12 (t, 
2H, J = 8 Hz), 0.07 (s, 9H); (13C NMR CDCl3, 100 MHz) δ 167.1, 166.2, 160.0, 159.9, 154.9, 
152.7, 141.24, 137.2, 132.3, 132.1, 131.9, 131.8, 130.6, 129.7, 129.5, 126.9, 125.8, 123.3, 122.1, 
120.1, 119.7, 117.3, 110.68, 64.8, 17.7, -1.1. High-res MS (ESI) calcd. for formula 
C29H26NO6SSi (M+1) requires 544.1172; found, 544.1245. 
 
1H NMR titration of 1.  A stock solution of 1 was prepared (9.05 x 10-2 M) in DMSO-D6 and 
distributed equally (97 μL) into 12 vials. To these vials was added varying equivalents of a 
second stock solution made of 1M TBAF/THF (7.44 x 10-2M) in DMSO-D6. 0.5 ml D2O was 
then added to each vial. 1H NMR spectra of each was then recorded.  The titration was repeated 
three times and the results were averaged. Conversion was calculated by measuring the ratio of 
DMSO-D6 signal integration with the integration of the –CH2 peak ( 4.42 ppm) in 1.    
 
Fluorescence titration of 2 and 3.  A stock solution of 2 was prepared (7.68 x 10-5M) in 
acetonitrile and distributed equally (52 μL) into vials.  These samples were titrated using varying 
equivalents of a 1M TBAF in THF solution.  The samples were then diluted with 1 mM 
phosphate buffered (pH = 7.0) water to 3.0 mL.  Excitation was carried out at 370 nm with all 
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excitation and emission slit widths at 2 nm.  The titration was repeated three times and the data 
were averaged.  The same experimental procedure was used in the titration of compound 3 
except the stock solution (2.3 x 10-6 M) was prepared in DMF, and the excitation of these scans 
was carried out at 440 nm. 
See Appendix I for NMR and MS of synthesized compounds, stability tests, and product studies. 
Conclusions 
In conclusion, we have shown that aryl phthalate esters are robust self-immolative linkers 
in water using a fluoride sensitive mask as a test case and phenolic outputs. The phthalate scaffold 
also appears to be highly promising for latent fluorophores, given the ~103 fluorescence 
enhancement upon releasing 7-hydroxycoumarin. Ester 2 represents an exquisite water-compatible 
fluoride sensor.  The advantages of this linker include a simple synthesis from inexpensive starting 
materials, aqueous stability and compatibility, but most importantly very fast release kinetics that 
lead to a biologically benign byproduct. The possibility of tuning the rate of release by chemical 
substitutions to the phthalate ring system, as well as the scope of this linker for different masking 
groups and output cargos, is currently under investigation in our laboratory.  These phthalate esters 
appear to be highly promising for use in biological and materials applications. 
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CHAPTER 2   
SELF-IMMOLATIVE PHTHALATE ESTERS SENSITIVE TO HYDROGEN PEROXIDE 
AND LIGHT 
Taken in part from: Mahoney, K. M.; Goswami, P. P; Syed, A.; Kolker, P.;  Shannan, B; Smith, 
E. A.; Winter, A. H., J. Org. Chem. 2014, 79, 11740. 
 
Introduction  
Self-immolative linkers have proven to be useful for connecting a cleavable masking 
molecule to an output cargo molecule.24,26,37-39  Upon exposure to an input stimulus that cleaves 
the mask, self-immolative linkers release their cargo. Self-immolative linkers have found 
applications in enzyme-activated prodrugs,10,20,40-46 chemical sensors,26,47 traceless linkers,48-51 
biological probes,52-55 and degradable polymers.3,56,57  Released chemical cargos are often 
biomolecules, drugs, or reporters such as fluorescent dyes. Ideally, self-immolative linkers should 
be simple in design, stable, compatible with water, and transformed into a benign byproduct upon 
releasing the output cargo.  Additionally, they should be easy to conjugate, readily adaptable to a 
variety of inputs and outputs, and quickly release the output cargo.  A drawback to known self-
immolative linkers is that cargo release rates can be slow,58 leading to loss of temporal resolution.  
  
Our group has recently reported aryl phthalate esters as fast-releasing self-immolative 
linkers.38  In this previous work, we demonstrated that a fluoride-sensitive masking group could 
release cargo phenols and phenolic-based fluorescent dyes. Phthalate self-immolative linkers 
exploit the rapid hydrolysis of esters with adjacent catalytic carboxylate moieties, a classic case of 
neighboring group participation32,59,60 (phenyl hydrogen phthalate releases phenol in < 5 sec in 
neutral water38).   Here, we demonstrate that phthalate esters masked with light- and peroxide-
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sensitive groups can release a coumarin dye upon exposure to light or peroxide.  Peroxide is an 
important biological signaling molecule, whereas light-releasable fluorescent dyes (pro-
fluorophores) have found application in monitoring dynamic events in real time 61-66 as well as 
recording images with sub-diffraction resolution at the nanometer level.67-70  
Results and Discussion 
 
Scheme 1. General unmasking scheme 
Both 1 and 2 were synthesized by the addition of the trigger molecule to phthalic anhydride 
followed by the addition of 7-hydroxycoumarin by either a DCC/DMAP or EDC/DMAP coupling.
  
Compounds 1 and 2 were synthesized and exposed to UV light and hydrogen peroxide, 
respectively. The reactions were monitored using fluorescence and 1H NMR spectroscopy. The 
titration of Compound 1 resulted in an 18-fold increase in fluorescence intensity and Compound 2 
showed an 8-fold increase as a result of releasing the free fluorescent dyes.    
The titrations of 1 and 2 were followed by fluorescence spectroscopy (Figure 1).  To aid 
with solubility, experiments with 1 were carried out by first dissolving the compound in DMF and 
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exposing the resulting solution to 350 nm light,  Asmall aliquot (7 μL) of the solution was then 
injected into buffered water (3.0 mL, pH 7.0, 1 mM phosphate buffer) and fluorescence was 
followed as a function of time.  Experiments for 2 were carried out by first dissolving the 
compound in DMF and titrating with increasing amounts of hydrogen peroxide.  This procedure 
was followed by injection of a small aliquot of the DMF/H2O2 solutions into buffered water for 
the fluorescence analysis. 
 
Figure 1. Fluorescence of compound 1 as a function of irradiation time (top); fluorescence of  2 
as a function of peroxide (bottom) in pH 7.0 buffer. Plot inserts depict fluorescence at the 
emission maxima (453 nm) vs. time of irradiation or equivalents of hydrogen peroxide. 
Compound 1 was stable in water/DMF mixtures in the absence of light for at least 1 day at 
room temperature (see SI for details).  Compound 2 did show some instability, as seen by a small 
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increase in fluorescence after a 16-hour period in a water/DMF mixture in the absence of hydrogen 
peroxide (see SI for spectra). Additionally, it is noteworthy that this structure 2 is quite unstable 
under the seemingly mild conditions required to synthesize it (e.g. DCC/DMAP ester coupling), 
possibly the result of the boronate ester under the reaction conditions catalyzing a spontaneous 
ester hydrolysis (2 is stable as a solid or dissolved in a solution void of hydrogen peroxide, 
however).  Additionally, NMR product studies after exposure to light and hydrogen peroxide 
indicate that the organic products are the expected free 7-hydroxy coumarin as well as phthalic 
acid.  The toxicity of phthalic acid has been studied due to its industrial use in the synthesis of 
phthalate plastics and esters; it has not been found to be very toxic in mice (LD50 (mouse) is 2.53 
g/kg).71,72  
Because 1 showed the largest increase in fluorescence intensity and the greatest stability 
during in vitro studies, we chose to use it for cellular experiments.  Compound 1 was incubated 
with Drosophila S2 cells and dye release was monitored using fluorescence microscopy.  See 
Figure 2. 
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Figure 2. Fluorescence images of a cell with no compound 1 (A-D) and cell incubated with 
compound 1 (50 µM) (E-H) as function of irradiation time. I) average fluorescence intensity as a 
function of time for i) four cells incubated with compound 1 and exposed to continuous irradiation 
for 35 minutes ii) four cells incubated with compound 1 and only exposed to irradiation briefly 
every 5 minutes to obtain an image iii) a cell without compound 1 and exposed to continuous 
irradiation for 35 minutes. Scale bar represents 5 µm in all images.  
The Drosophila S2 cells were loaded with 1 and subjected to continuous irradiation with 
335 nm light. Fluorescence images were collected every 500 ms for a total of 33 minutes (Figure 
2). Fluorescence emission was observed at 450 nm. Fluorescence intensity for Figure 2, i-iii, was 
taken from the periphery of the cell where the concentration of 1 was highest.  As shown in Figure 
2 E-H, at the beginning of the experiment there was minimal fluorescence; however, after exposure 
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to light a gradual increase in fluorescence is seen for up to 33 minutes.  The initial fluorescence 
seen at time zero can be attributed to cellular auto fluorescence, which undergoes initial bleaching 
prior to significant release of the free coumarin dye. Control studies were performed to make sure 
the fluorescence was due to the controlled release of 7-hydroxycoumarin by irradiation. Figure 2, 
A-D shows that there is minimal change in fluorescence of cells when irradiated without being 
loaded with 1. Another control study (Figure 2, ii) was performed with cells incubated with 1 but 
not exposed to irradiation.  There was an initial fluorescence signal due to cellular auto 
fluorescence; however, a decrease in fluorescence signal is seen, eventually leveling off to an 
intensity similar to that of the unloaded cells, indicating that the 1 does not release the dye in the 
absence of irradiation.  
The cytotoxicity of 1 in the cells was determined by incubating the cells (1×106 cells/mL) 
with different dilutions (100 µM, 50 µM, 25 µM, 12.5 µM, 6.25 µM and 3.125 µM) of 1 in 
phosphate buffer saline (PBS, pH=7.1) for an hour.  At a compound concentration of 50 μM, 83% 
of the cells remained viable after an hour and this concentration was used in all fluorescence 
imaging cell studies. 
Experimental 
Synthesis of 2-(Nitrobenzyl) Hydrogen Phthalate. Phthalic acid (0.100 g, 0.675 mmol) and 2-
nitrobenzyl alcohol (0.103 g, 0.675 mmol) were refluxed in toluene under argon overnight.  The 
crude product was collected by evaporation under reduced pressure.  The resulting mixture was 
dissolved in ethyl acetate and the product was extracted with aqueous sodium bicarbonate followed 
by acidification with 1 M aqueous hydrogen chloride.  Final collection of a white solid was 
performed by vacuum filtration.  The product was dried under vacuum and used without any 
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further purification (0.203 g, 36%); 1H NMR (400 MHz, DMSO-d6) δ 13.35 (s, 1H), 8.15 (dd, J = 
8.1, 1.2 Hz, 1H), 7.85 – 7.60 (m, 7H), 5.63 (s, 2H). δ; 13C (DMSO-d6, 100 MHz) 13C NMR (100 
MHz) δ 168.4, 167.6, 147.8, 134.6, 132.1, 131.9, 131.9, 131.5, 129.9, 129.8, 129.4, 128.8, 125.3, 
64.1; mp 142-145°C; HRMS (ESI) m/z: [M + Na]+ for C15H11NNaO6 requires 324.0479, found 
324.0480 
Synthesis of 7-Hydroxycoumarinyl 2-(Nitrobenzyl) Hydrogen Phthalate 1. 2-(nitrobenzyl) 
hydrogen phthalate (0.200 g, 0.664 mmol), N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide 
hydrochloride (0.126 g, 0.657 mmol), and 4-N,N-dimethylaminopyridine (0.089 g, 0.728 mmol) 
were dissolved in dry DCM (10 mL), followed by continuous stirring of the solution.  7-
hydroxycoumarin potassium salt (0.132 g, 0.660 mmol) and 18-crown-6 (0.174 g, 0.660 mmol) 
were added next to the reaction mixture, and the reaction was stirred under an argon atmosphere 
for 12 h. The product was washed with an aqueous saturated sodium bicarbonate solution.  The 
solvent was then removed under reduced pressure to yield the crude product as a white solid.  Flash 
chromatography (Hex/EtOAc, 30:70  Chloroform/MeOH 95:5) gave the pure final product 
(0.123 g, 42%).  1H NMR (DMSO-d6, 400 MHz) δ 8.16 – 8.08 (m, 2H), 8.06 – 7.91 (m, 2H), 7.90 
– 7.72 (m, 5H), 7.67 – 7.56 (m, 1H), 7.34 (d, J = 2.2 Hz, 1H), 7.23 (dd, J = 8.4, 2.2 Hz, 1H), 6.53 
(d, J = 9.6 Hz, 1H), 5.74 – 5.69 (m, 2H), 1.24 (s, 1H), 0.84 (t, J = 6.8 Hz, 1H);  13C (DMSO-d6, 
100 MHz) δ 166.3, 165.7, 160.0, 154.5, 153.0, 148.0, 144.2, 134.5, 132.8, 131.0, 130.3, 130.0, 
129.9, 129.8, 125.3, 118.6, 117.4, 116.2, 110.2, 79.6, 79.4, 79.1, 64.4; mp >260°C; HRMS (ESI) 
calcd for formula C24H15NO8 [M + H]
+ requires 446.0870, found 446.0872. 
Synthesis of 4-(Hydroxymethyl)benzeneboronic Acid Pinacol Hydrogen Phthalate.  
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Phthalic anhydride (0.049 g, 0.294 mmol), 4-(hydroxymethyl)benzeneboronic acid pinacol (0.077 
g, 0.329 mmol) were refluxed in toluene overnight.  The crude product was collected by 
evaporation under reduced pressure.  The resulting mixture was dissolved in ethyl acetate and the 
product was extracted with aqueous sodium bicarbonate followed by acidification with hydrogen 
chloride.  Vacuum filtration was used to collect the white solid. The product was dried under 
vacuum and used without any further purification (0.045 g, 40%); 1H NMR (DMSO-d6, 400 MHz) 
δ 7.85 (s, 1H), 7.72 (m, 6H), 7.52 (d, 1H, Ј = 0.8 Hz), 1.36 (s, 12H); 13C (DMSO-d6, 100 MHz) δ 
168.4, 167.9, 139.4, 137.0, 135.0, 134.7, 132.6, 131.9, 129.4, 128.8, 127.8, 127.4, 84.2, 67.1, 25.1; 
mp 121-123°C; HRMS(ESI) calcd for formula C21H23BO6 (M – H+)- requires 380.1551, found 
380.1550 (mass calculated using boron isotope 10B). 
Synthesis of 7-Hydroxycoumarinyl 2-(4-Hydroxymethyl)benzeneboronic Phthalate 2. 4-
(hydroxymethyl)benzeneboronic acid pinacol hydrogen phthalate (0.100 g, 0.262 mmol), N,N-
dicyclohexylcarbodiimide (0.068 g, 0.314 mmol), and 4-N,N-dimethylaminopyridine (0.011 g, 
0.087 mmol) and 18-crown-6 ether (0.069 g, 0.262 mmol) were dissolved in dry DMF (3 mL), 
followed by continuous stirring of the solution.  7-hydroxy coumarin potassium salt (0.052 g, 0.262 
mmol) was next added to the reaction mixture, and the reaction was stirred under an argon 
atmosphere overnight.  The dicyclohexylurea byproduct was filtered off as a white solid.  The 
solvent was then removed under reduced pressure to yield the crude product as a white solid.  Flash 
chromatography (Hex/EtOAc, 50:50) gave the pure final product (5.6 mg, 4.1%). 1H NMR (400 
MHz, DMSO-d6) δ 8.10 (d, J = 9.6 Hz, 1H), 8.02 – 7.90 (m, 2H), 7.87 – 7.75 (m, 3H), 7.62 (dd, 
J = 7.0, 1.3 Hz, 2H), 7.43 (d, J = 7.6 Hz, 2H), 7.32 (d, J = 2.1 Hz, 1H), 7.18 (ddd, J = 8.5, 2.2, 0.8 
Hz, 1H), 6.52 (dd, J = 9.6, 0.8 Hz, 1H), 5.40 (s, 2H), 1.27 (d, J = 0.8 Hz, 12H); 13C (DMSO-d6, 
100 MHz) δ 166.6, 165.8, 160.3, 154.7, 153.3, 142.8, 138.2, 135.1, 131.8, 131.6, 131.5, 129.5, 
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129.2, 128.6, 127.5, 118.4, 116.8, 116.2, 110.4, 80.9, 67.6, 24.9; mp; HRMS(ESI) calcd for 
formula C30H27BO8 (M + H)
+ requires 526.1904, found 526.1908. (mass calculated using boron 
isotope 10B). 
See Appendix II for NMR and MS of compounds, stability tests, and product studies. 
Conclusions 
In conclusion, we have shown that aryl phthalate self-immolative linkers are easily 
conjugated with the light sensitive 2-nitrobenzyl ethanol group and the hydrogen peroxide 
sensitive group 4-(hydroxymethyl)phenylboronic acid pinacol ester.  Compound 2 could be 
potentially useful as a hydrogen peroxide sensor. Compound 1 is of interest because it is able to 
deliver cargo in a temporally and spatially controlled manner using irradiation. Release of caged 
7-hydroxycoumarin occurs upon irradiation within S2 cells.  We note finally that the fast rates of 
hydrolysis of phthalate self-immolative linkers may make these structures good candidates for 
domino self-immolative linkers,17,18,73-75 wherein a single input reaction results in the spontaneous 
release of numerous cargo molecules.  Current domino self-immolative linkers tend to have slow 
kinetics of release.58 A recent method to synthesize aryl mellitic acid esters76 may enable these 
structures to be used within fast-releasing domino self-immolative systems. 
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GENERAL CONCLUSIONS FOR PART 1 
Aryl phthalate esters are fast and robust self-immolative linkers in water. This linker is 
easy to conjugate and releases output phenols within seconds upon cleaving a fluoride-sensitive 
mask to yield a benign phthalic acid byproduct, making these linkers useful as fluoride sensors 
and promising for use in biological and materials applications. 
Self-immolative aryl phthalate esters were conjugated with cleavable masking groups 
sensitive to light and hydrogen peroxide.   The phthalate linker releases the fluorescent dye 7-
hydroxycoumarin upon exposure to light or H2O2 leading to an increase in fluorescence. The 
light sensitive aryl phthalate ester is demonstrated as a pro-fluorophore in cultured S2 cells. 
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INTRODUCTION FOR PART II 
 
PHOTOCLEAVABLE PROTECTING GROUPS 
Photoremovable protecting groups, sometimes called photocages or phototriggers, are 
popular light-sensitive chemical moieties that mask substrates through covalent linkages that 
render the substrates inert. Upon irradiation, the masked substrates are released, restoring their 
reactivity or function. 
 
 
Figure 1. Un-caging scheme of photoremovable protection groups 
 
Barltrop et al.1 were among the first to introduce a photochemical deprotection reaction of 
a biologically significant substrate, glycine was released from N-benzyloxycarbonyl glycine.  
 
 
Figure 2. Barltrop’s photochemical deprotection of glycine 
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This discovery lead to an outpouring of several additional photoremovable protecting 
groups (PPGs). The most commonly utilized include: o-nitrobenzyl,2-4 phenacyl,5 acridinyl,6 
benzoinyl,7,8 coumarinyl,9 xanthenyl,10 and o-hydroxynaphthyl11 structures.  
 Kaplan et al.4 introduced the term “cage” in the 1970s to describe a photocage’s 
deactivating influence on the biological substrate to which it is covalently attached.  Ideally, the 
cage detaches only through the action of light allowing for good temporal and spatial control.  It 
is also important that the photoremovable protecting group possess several other desirable 
properties.  Several researches in the field, including Sheehan and Umezawa12 and Lester and 
Nerbonne13 developed a list of properties the ideal photocage would possess14: 
 
1. The substrate, caged substrate, and photoproducts have good aqueous solubility for   
biological studies. For synthetic applications, this requirement is relaxed. 
2. The photochemical release must be efficient (e.g., Φ > 0.10). 
3. The departure of the substrate from the protecting group should be a primary 
photochemical process (i.e., occurring directly from the excited state of the cage 
chromophore). 
4. All photoproducts should be stable to the photolysis environment. 
5. Excitation wavelengths should be longer than 300 nm and must not be absorbed by the 
media, photoproducts, or substrate. 
6. The chromophore should have a reasonable absorptivity (a) to capture the incident light 
efficiently. 
7. The caged compounds, as well as the photoproduct from the cage portion, should be 
inert or at least benign with respect to the media, other reagents, and products. 
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8. A general, high-yielding synthetic procedure for attachment of the cage to the substrate 
must be available. 
9. In the synthesis of a caged substrate, the separation of caged and uncaged derivatives 
must be quantitative. This is also necessary for the deprotection process for synthetic 
applications 
It may be the case that a photocage not fitting all of the criteria above could be very useful; 
however, if a photocage lacks many of the traits above then there is a good chance it is not a 
reasonable photocage.14 
Many photoremovable protecting groups have been synthesized that cage a target agent for 
biochemical or biological studies.  There have been many uses of caged molecules in biology 
including caged ATP, 4,3 nuerotransmitters, 15,16 pharmaceuticals,17 etc.    
Photochemistry. Photocleavage of a molecule occurs when the molecule absorbs light of the right 
intensity and wavelength resulting in a promotion of a single electron from a bonding or non-
bonding orbital (HOMO) to an unoccupied molecular orbital (LUMO).   
 
 
 
 
 
 
Figure 3.  A schematic of promotion of an electron via light from ground state to excited state 
followed by intersystem crossing (ISC) to the triplet excited state. 
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The initial excited state is a singlet state which can undergo intersystem crossing (ISC) 
leading to an excited triplet state.18  Photocleavage can occur from either the excited singlet or 
excited triplet state by mechanisms such as bond homolysis, heterolysis, solvolysis, electron 
transfer, photocyclization, and photooxygenation.18  
 
 
 
 
The photocages o-nitrobenzyl, coumarin-4-ylmethyl, and xanthenyl structures are some of 
the most common and promising to date.    
 
Figure 4.  Common photocage backbones 
   
O-nitrobenzyl. O-nitrobenzyl and its derivatives are by far the most commonly used PPG in spite 
of having many disadvantages.  They absorb light in the UV region (λmax = 250-350, typically) 
making them toxic to cellular structures.  Also, photolysis leads to potentially toxic nitroso 
byproducts that can absorb light strongly.19 One attractive feature is that cleavage quantum yields 
of up to 0.49–0.63 has been reported in the literature (releasing 1-(2-nitrophenyl)ethyl phosphate 
esters).20 
Much work has been done to improve the o-nitrobenzyl system in terms of quantum yield, 
rate of release, and increasing light absorbance to longer wavelengths.  Many studies have been 
52 
 
 
 
done to probe the mechanism of release 21, 22,4 in order to better understand the system and improve 
it.  In general, substitution of the benzylic position affects quantum yield 23,24,25. However, it also 
introduces a chiral center, which can be a drawback when protecting chiral molecules such as 
amino acids and carbohydrates.26 Modification of the aromatic ring tends to affect the absorbance.  
Addition of two methoxy groups on the aromatic ring increases the absorbance to longer 
wavelengths ( >350 nm).  Other substituents have been studied to red-shift the absorption 
wavelength.27,28,29,30 Extending the aromatic core as a naphthalene31 or 7-methoxynapthalene32 
shifted the absorption wavelength to 380 nm however, it is still not in the biological window. 
Coumarinyl. As an alternative to the o-nitrobenzyl cages, several coumarinyl cages (Fig. 4, B) 
have been established.  Coumarinyl PPGs were introduced by Givens as a photoactivatable 7-
methoxy coumarinyl-4-methyl releasing a diethyl phosphate.9  Appealing aspects of coumrinyl 
cages include large molar absorption coefficients at longer wavelengths than the nitrobenzyl cages, 
fast release rates, and they are fluorescent allowing for monitoring of reaction progress.26  They 
absorption maxima from 320 nm to 400 nm depending on the substitutents on the coumarin 
backbone structure. 
 Time resolved absorption studies have found the heterolytic bond cleavage to be very fast 
with rate constants near 2 x 1010 s-1 (releasing a phosphate ester).33  This is one of the most rapid 
photorelease rates for any caged compound.  One downfall is that recombination of the tight ion 
pair regenerates the ground state derivative leading to a non-productive pathway.  Also, because 
coumarin is a fluorescent dye, fluorescence is another competing pathway to productive release of 
the caged compound.34  
The mechanism of coumarinyl photorelease begins with an initial absorption of light 
followed by relaxation to the lowest , * singlet excited state.26  At this point, there can be 
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radiationless decay, fluorescence, or productive heterolytic C-X bond cleavage.26  The 
coumarinylmethyl cation formed through heterolytic cleavage can then react with nucleophiles or 
solvent to form a new stable coumarinyl product (Figure 14).26 
 
 
Figure 5. Coumarinyl photorelease scheme 
 
Xanthenyl. A recently studied and potentially useful PPG is based on a xanthene backbone (Fig. 
4, C). Wirz, Klan, and co-workers10 have shown that (6-hydroxy-3-oxo-3H-xanthen-9-yl)methyl 
and derivatives release diethyl phosphate or carboxylic acid upon irradiation with visible light 
(over 500 nm) and quantum yields of 0.005 – 0.04.10 However, these systems are synthetically 
challenging and have undesirable protonation and tautomerization equilibria.10 The fate of the 
xanthene based PPGs is an unfortuante one because a photoremovable protecting group that 
absorbs at wavelengths >500 nm would tremendously increase PPG application in biological 
systems. 
Structure- Reactivity Relationship. It is clear that photocages are important tools in chemistry 
and biology, however, most have been serendipitously discovered.  It seems rather challenging to 
rationally design a cage that has a productive uncaging pathway versus fluorescence pathway or 
other non-productive pathway.  This difficulty comes from a lack of understanding of the structure- 
reactivity relationship that leads to photoheterolysis in the excited state.  Recently, Winter et al.35 
has addressed this issue and has developed a structure- reactivity relationship to predict excited 
hν 
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state photo-heterolysis based on the presence of a nearby conical intersection.  A conical 
intersection is a geometry where the ground state and the excited state have the same energy, in 
other words, a point where two potential energy surfaces intersect.34  Fig. 6 A shows a 
representation of a conical intersection (purple sunburst) where the ground state (blue) and excited 
state (red) potential energy surfaces intersect.  This intersection allows an efficient path from the 
excited state to the ground state ion pair.34  The closer in energy the gap between the excited state 
surface and the ground state surface is, the faster and more efficient this path will be.34  It has been 
found computationally that carbocations favored from photoheterolysis tend to have nearby, low-
energy conical intersections, while stable carbocations from thermal heterolysis tend to have high-
energy, distant conical intersections.35  
 
 
 
Figure 6. Schematic of Winter’s hypothysis that a destabilized ground state and a stabilized 
excited state can lead to a favorable, nearby conical intersection (A), whereas it is unlikely that a 
stabilized ground state will have a nearby conical intersection (B).35  
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The idea that these photoheterolysis reactions may be governed by conical intersection 
control could facilitate the design of new photocages with improved light absorbing properties by 
searching for substrates leading to carbocations with a favorable built-in conical intersection.  
Furthermore, the structures that have nearby conical intersections tend to undergo photoheterolysis 
reactions releasing leaving groups to generate destabilized carbocations (anti-aromatic ions, donor 
unconjugated ions, dicoordinated aryl/vinyl cations, the opposite of thermal heterolysis 
preferences. 
 The following is a list developed by the Winter Lab that presents ideal photocage 
properties: 
1. The photocage must be uncaged with visible light, preferably in the biological window. 
2. The photocage must be thermally stable in the dark 
3. The photocage must be biologically benign and convert to benign byproducts 
4. The photocage must have a potent light-absorbing chromophore and high quantum 
yields of release. 
5. The photocage must have fast photochemical release of the substrate from the excited 
state 
6. The photocage must be water-soluble and water compatible 
7. The photocage must be able to release a variety of functional groups 
8. The photocage must be easily synthesizable 
BODIPY. A computational investigation by Winter, et. al.36 found that  meso-substituted 
BODIPY structures would most likely undergo photoheterolysis in the excited state by way of a 
conical intersection. 
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Figure 7. meta-substituted BODIPY dyes are computationally reasoned to  undergo heterolysis 
in the excited state.   
BODIPY dyes have excellent optical properties and would be an ideal photoremovable 
protecting group candidate.  They absorb in the visible to near-IR, they have large molar 
absorbtivities (Ɛ > 60,000 M-1 cm-1) and sharp absorption peaks.  Also, the syntheses of 
BODIPYs are well established and the core structure is easy to modify.  The following chapters 
describe the synthesis and use of meso-substituted BODIPY dyes as a photocage for acetic acid.  
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CHAPTER 3 
BODIPY-DERIVED PHOTOREMOVABLE PROTECTING GROUPS UNMASKED WITH 
GREEN LIGHT 
Taken in part from: Goswami, P.P.; Syed, A.; Beck, C.L.; Albright, T.R.; Mahoney, K.M.; 
Unash, R.; Smith, E.A.; Winter, A.H. J. Am. Chem. Soc., 2015, 137, 3787.  
 
Introduction 
Photoremovable protecting groups, sometimes called photocages or phototriggers, are 
popular light-sensitive chemical moieties that mask substrates through covalent linkages that 
render the substrates inert. Upon irradiation, the masked substrates are released, restoring their 
reactivity or function.  While photocages have important applications in areas such as organic 
synthesis,1-3 photolithography,4,5 and light-responsive organic materials,6-8 these structures are 
particularly prized for their ability to trigger biological activity with high spatial and temporal 
resolution9-13.  Examples of such chemical tools include photocaged proteins,14-16 
nucleotides,17,18 ions,19-23 neurotransmitters,24,25 pharmaceuticals,26,27 fluorescent dyes,28-30 and 
small molecules31,32 (e.g., caged ATP).  These biologically relevant caged molecules and ions 
can be released from the caging structure within particular biological microenvironments using 
pulses of focused light. The most popular photocages used in biological studies are the o-
nitrobenzyl systems31-33 and their derivatives, but other photocages that see significant use 
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include those based on the phenacyl,34 acridinyl,35 benzoinyl,36,37 coumarinyl,38 and o-
hydroxynaphthyl structures.39  Unfortunately, with few exceptions described below, 40,41 a 
serious limitation of most popular photocages is that they absorb mostly in the ultraviolet where 
the limited penetration of UV light into tissues largely restricts these studies to fixed cells and 
thin tissue slices.  Furthermore, prolonged exposure of cells or tissues to UV light can lead to 
cellular damage or death. 
     Consequently, new photocaging structures that absorb visible light are urgently needed.  
Advantages of visible light irradiation include diminished phototoxicity compared to UV light 
and deeper optical penetration into tissue.  Additionally, visible light photolysis can be 
performed with cheap lamps and Pyrex glassware, while UV photolysis requires expensive UV 
sources.  Unfortunately, the major problem that has hindered the development of new photocages 
that absorb visible light is the lack of a structure-reactivity relationship for excited state 
heterolysis.  That is, it is difficult to predict a priori which structures, when irradiated with light, 
will undergo an efficient photoheterolysis reaction.  Thus, attempts to prepare visible light 
absorbing photocages have mostly bypassed this problem by using metal-ligand photoreleasing 
systems41-43 or by using creative indirect schemes.  Examples of such creative schemes include 
upconverting nanoparticles with surface-attached UV-absorbing photocages44-46 or release 
mediated by photoinduced electron transfer with a sacrificial electron donor.47   
      However, visible light absorbing organic structures that offer simple photorelease schemes 
and structures would potentially make a more compelling case for widespread use in 
biologically-oriented labs.48  A recent computational study performed in our lab suggested the 
hypothesis that photoheterolysis reactions may be under conical intersection control.49  That is, 
photoheterolysis of C-LG (carbon—leaving group) bonds to generate ion pairs50 may be favored 
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if the ion pair has access to a nearby productive conical intersection that provides an efficient 
channel for the excited state of the photoprecursor to decay to the ground-state ion pair.  Because 
conical intersections are challenging to compute, we further suggested using the vertical energy 
gap of the carbocation to its first excited state as a simple predictor of a nearby conical 
intersection (CI).  A low S0-S1 energy gap of the cation would suggest the possibility of a nearby 
CI between the S0 and S1 surfaces, and the potential for a productive mechanistic channel for the 
photochemistry to proceed from the excited state of the photocaged precursor to the ion pair.   
Thus, to find visible light absorbing photocages we searched for potential photocaging 
structures that would generate carbocations with low-lying diradical states.  A time-dependent 
density functional theory (TD-DFT) computational investigation of carbocations attached to the 
BODIPY scaffold at the meso position indicated that these ions have low-lying excited states. For 
example, the TD-DFT computed S0-S1 vertical energy gap of the carbocation derived from C-O 
scission of 2 is 8 kcal/mol (TD-B3LYP/6-311+G (2d,p), suggesting a near-degenerate diradical 
configuration.  Indeed, all of the cations derived from C-O scission of 1-6 have vertical gaps < 13 
kcal/mol (see SI for computational details), and have singlet states with considerable diradical 
character.  Large singlet stabilizations upon switching from restricted  spin-purified unrestricted 
singlet computations indicate that the singlet states can be described as diradicals or possessing 
considerable diradical character (see SI for details). Thus, the exact vertical energies from the TD-
DFT computations are to be viewed with suspicion, but it is clear that there are low-energy 
diradical forms for these ions, suggesting a CI between the closed-shell singlet and singlet diradical 
forms of the carbocations in the vicinity of the ion pair geometry.  Further, the singlet-triplet gaps 
of all the carbocations derived from 1-6 are ~5 kcal/mol in favor of the triplet state, suggesting that 
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the “carbocations” produced by heterolysis of 1-6 may in fact be better described as ion diradicals 
in their thermodynamic ground state than by traditional closed-shell carbocation structures.51  
Results and Discussion 
Encouraged by these computational studies, we synthesized structures 1-6 as photocages 
for acetic acid. Advantages of the BODIPY scaffold include simple syntheses, a compact 
structure, known biological compatibility,52 and high extinction coefficients in the visible.53  
Photorelease studies, described below, indicate that these structures release carboxylic acids 
upon photolysis with wavelengths >500 nm.   
 
  
Figure 1.  (a) Possible pathway for the photolysis of photocaged acetic acid; (b) Substrates 
described in this study. 
The observed substrate release rate as a function of photolysis time is quantified by the 
quantum efficiency parameter (ε Ф), which is the product of the extinction coefficient at the 
irradiation wavelength (ε) and the quantum yield of release (Ф).  Extinction coefficients for 1-6 
were determined by UV-Vis spectroscopy (see Table 1).  To compute the quantum yields of 
photorelease (Ф), the flux of a 532 nm laser exci-tation beam (ND:YAG, 1st harmonic) was 
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determined using potas-sium ferrioxalate actinometry.  Release of acetic acid as a function of 
laser irradiation time in MeOH was followed by quantitative LC/UV (see SI for details).  Each 
quantum yield reported is the average of 3 separate runs.  Identical actinometry measurements 
performed after photolysis demonstrated high flux stability of the laser.  Additionally, repeating 
the quantum yield measurement for 2 on a different day with a different laser power setting (in 
triplicate) gave essentially the same value for the quantum yield, indicating reproducibility.  A 
preparative photolysis of 2 in MeOH gave a meso-substitued methyl ether adduct as a stable 
photoproduct of the photocaging moiety, suggestive of solvent trapping of an intermedi-ate 
carbocation.  Additionally, lamp photolysis of 2 showed no major difference in release of acetic 
acid under argon or air atmos-phere.  Curiously, unlike 1-4 and 6, the brominated compound 5 
was found to be unstable.  It decomposes after 1 day stored on the shelf in the dark, and 
photolysis of freshly prepared and purified 5 led to secondary products in addition to acetic acid 
release, and photolysis was accompanied by rapid solution bleaching.  Conse-quently, we were 
not confident in our quantum yield measurements for 5 and excluded it from Table 1.  Probably, 
5 also has access to alternative photochemical pathways (e.g., C-Br homolysis) and thermal 
degradation channels. Photocaged compounds 1-4 and 6 are thermally stable in the dark.  Boiling 
these compounds in MeOH for 1 h in a foil-wrapped vessel led to no change in the 1H NMR 
spectrum. 
In general, the quantum efficiencies for 1-4 and 6 are lower or comparable with the 
popular caged o-nitrobenzyl or coumarinyl systems.9  Quantum yields for 1-4 are lower than 
those for typical o-nitrobenzyl photocaged structures or coumarinyl systems, but this lower 
quantum yield is compensated by the much higher extinction coefficients of the BODIPY 
chromophores compared to the o-nitrobenzyl chromophore, leading to reasonable quantum 
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efficien-cies.  The iodinated derivative 6 has the largest quantum efficiency, comparable to that 
of some caged o-nitrobenzyl systems, but with a λmax at ~550 nm rather than in the UV (the 
parent o-nitrobenzyl system has a λmax of ~280 nm while a popular dimethoxy analog has a 
λmax of ~350 nm).  A plausible explanation for the higher quantum yield of 6 is that the iodine 
atoms promote intersystem crossing (ISC) to a triplet state, which are usually longer lived than 
singlet excited states, giving more time for release. For example, the phenacyl photocage 
derivatives described by Givens undergo pho-torelease in the triplet state.34 The plausibility of a 
rapid ISC event is supported by the very weak fluorescence of solutions of 5 and 6, compared to 
solutions of 1-4. 
 
Table 1.  Optical properties and quantum efficiencies of 1-6.  Quantum yields of acetic acid 
release (Ф) determined by ferrioxalate actinometry in MeOH with a 532 nm ND:YAG laser 
source and release followed using quantitative LC-UV (Ф values are the average of 3 runs).   
  
 λmax (nm) λem (nm) ε (x 104 M-1 cm-1) Ф (x 10-4) ε Ф  
(M-1cm-1) 
1 519 527 5.7 6.4 37 
2 515 526 7.1 9.9 70 
3  544 560 6.2 9.5 59 
4  544 570 4.8 4.0 19 
5  545 575 -- -- -- 
6  553 576 4.9 23.8 117 
 
The UV-Vis spectra and fluorescence spectra of 1-6 are shown in Figure 2.  These 
structures absorb be-tween 515 nm and 553 nm (and emit between 520 nm and 580 nm), typical 
of simple BODIPY dyes, and feature large extinction coeffi-cients (~50,000-70,000 M-1cm-1). 
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Figure 2. Normalized absorbance and fluorescence spectra of 1-6. 
To test the viability and usefulness of the BODIPY derived photocages in biological 
systems, compound 7 was synthe-sized. 2,4-dinitrobenzoic acid is a known54 fluorescence 
quencher for BODIPY dyes.  This quencher was coupled with our BODIPY moiety using a 
standard DCC/DMAP ester coupling reaction.  We anticipated that 7 would be weakly 
fluorescent, but upon photore-lease of the quencher the fluorescence would increase.  Indeed, 
when 7 was irradiated with a mercury lamp (excitation = 500 nm, see SI) in a cuvette and its 
fluorescence was plotted over time (Fig-ure 3 N),  there was a growth in fluorescence attributed 
to release of the quencher. Photorelease of the quencher was confirmed by 1H NMR photolysis 
studies.  As a control, similar steady state fluores-cence measurements were performed over time 
for compound 7 in the dark without light exposure, leading to essentially no change in 
fluorescence.  
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Figure 3. Fluorescence images of S2 cells with no BODIPY com-pound (A-D), cells incubated 
with compound 2 (E-H) and cells incubated with compound 7 (I-L) as a function of irradiation 
time (top). Scale bar is 20 µm (shown in panel A) and is the same for all the images. Images 
were adjusted to same contrast in each row. Average of at least 32 cells fluorescence intensity 
profile versus irradiation time using 100% lamp power for excitation in cells (M). Increase in 
free BODIPY fluorescence signal over time with quencher release from compound 7 in BES 
buffer (N). Plot insert (N) depicts the difference in growth of fluorescence vs time for compound 
7 with (i) and without (ii) light irradiation in a cuvette. 
Compound 2 and 7 were then incubated with Drosophila S2 cells and monitored using 
fluorescence microscopy (Figure 3 A-L). The Drosophilia S2 cells loaded with 2 and 7 were 
irradiated continu-ously with 500 nm light.  Fluorescence images were collected every 36 ms for 
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a total of 10.8 seconds.  The fluorescence intensity for compound 7 inside cell as shown in 
Figure 3I-L increases rapidly.  This increase in fluorescence can be attributed to the release of 
the quencher.  The same fluorescence study with 2 as a control in Fig-ure 3E-H shows no such 
increase in fluorescence. For 2, the leav-ing group is acetate, which is not a quencher.  Thus, 
little change in the fluorescence would be anticipated upon photorelease of acetic acid from this 
moiety.  The background decay in fluorescence for both 2 and 7 can be attributed to 
photobleaching under the intense focused light.  Parts A-D of Figure 3 show that there is a 
minimal change in fluorescence of cells when they are irradiated without being loaded with 
compound 2 or 7.  Figure 3M shows the fluores-cence intensity change over time for cells 
incubated with compound 2, 7, and the control experiments without any compound.   
Cytotoxicity of compounds were measured with trypan blue exclu-sion assay. All values are 
normalized with the control cells which were not incubated with any compound. At a compound 
concentra-tion of 25 µM, 97% for compound 2 and 92% for compound 7 remained viable after 
1h.   
Experimental 
Compounds 1, 2, 3, and 4 were synthesized as previously described. (All spectra for these 
compounds matched those previously reported.) 
Synthesis of 5. Compound 2 (0.1 g, 0.31 mmol, 1 equiv), was dissolved in 3 mL of dry THF 
under argon and cooled to -78 °C. N-Bromosuccinimide (0.23 g, 1.25 mmol, 4 equiv) dissolved 
in 2 mL of dry THF was added dropwise to the solution. The reaction mixture was stirred for 15 
min at -78 °C, after which it was warmed to room temperature and stirred for an additional 5 h. 
The solvent was evaporated under reduced pressure. The solid residue was loaded onto a silica 
gel flash column and eluted with hexane-ethyl acetate 90:10 vol/vol to give 5 as dark red crystals 
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(0.14 g, 95% yield). Mp 230°C (decomp); 1H NMR (600MHz, CDCl3): δ 5.32 (s, 2H), 2.63 (s, 
6H), 2.40 (s, 6H), 2.15 (s, 3H); 13C NMR (150MHz, CDCl3) δ 170.45, 155.29, 138.93, 133.85, 
131.87, 113.10, 58.04, 20.69, 14.94, 14.08; High-res MS (ESI) for formula 
C16H17BBr2F2N2O2Na
+, Calc. 497.9646, Found 497.9646. 
Synthesis of 6. Compound 2 (0.1 g, 0.31 mmol, 1 equiv), was dissolved in 3 mL of dry THF 
under argon and cooled to -78 °C. N-Iodosuccinimide (0.18 g, 2.5 mmol, 4 equiv) dissolved in 2 
mL of dry THF was added dropwise to the solution. The reaction mixture was stirred for 15 min 
at -78 °C, after which it was warmed to room temperature and stirred for an additional 5 h. The 
solvent was evaporated under reduced pressure. The solid residue was loaded onto a silica gel 
flash column and eluted with dichloromethane to give 6 as dark purple crystals (0.07 g, 39% 
yield). Mp 210°C; 1H NMR (600MHz, CDCl3): δ 5.31(s,2H), 2.59(s, 6H), 2.38(s, 6H), 2.14(s, 
3H);  13C NMR (150MHz, CDCl3) δ 170.43, 158.06, 143.60, 132.92, 132.70, 87.38, 58.35, 
20.68, 18.29, 16.47; MS (ESI) for formula C16H17BI2F2N2O2Na
+, Calc. 593.9369, Found 
593.9378. 
Synthesis of 7. 2,4 dinitrobenzoic acid (0.054g, 0.194mmol, 1 equiv) was dissolved in 3ml of 
dry DCM under argon in room temperature. DCC (N,N’-Dicyclohexylcarbodiimide) (0.048mg, 
0.233mmol, 1.2 equiv) dissolved in 3ml of dry DCM was added dropwise to the solution. 4-
DMAP (4-Dimethylaminopyridine) (0.001g, 0.007mmol, 0.04equiv) was added to this solution. 
Next, 7a (0.049, 0.233mmol, 1.2equiv) dissolved in 3ml of dry DCM was slowly added to the 
solution. The reaction mixture was stirred for 16 h until its completion. The reaction mixture was 
filtered to get rid of DCU (Dicyclohexyl Urea) by-product. The filtrate was evaporated under 
reduced pressure. The solid residue was loaded onto a silica gel flash column and eluted with 
hexane-ethyl acetate 80:20 vol/vol to give 7 as a dark orange crystals (0.08g, 91% yield). 1H 
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NMR (600MHz, CDCl3): δ 8.86(d, J = 2.2Hz, 1H), 8.54(dd, J = 8.4Hz, 1H), 7.86(d, J = 8.4Hz, 
1H), 6.11(s, 2H), 5.69(s, 2H), 2.53(s, 6H), 2.44(s, 6H);  13C NMR (150MHz, CDCl3) δ 163.79, 
157.46, 149.27, 141.54, 132.59, 132.72, 131.20, 130.97, 128.07, 122.88, 120.10, 60.28, 15.89, 
14.89; MS (ESI) for formula C21H19BF2N4O6Na
+, Calc. 495.1258, Found 498.1271. 
See Appendix III for product studies of the compounds. 
Conclusions 
BODIPY-derived photocages unmask carboxylic acids with green light excitation >500 
nm and photocleavage can be carried out in living cells.  These photocages are promising 
alternatives for the popular o-nitrobenzyl photocaging systems, being easy to synthesize, 
utilizing a biocompatible chromophore, and having superior optical properties to the most 
popular photocages in current use.  More generally, our strategy of identifying new photocages 
by searching for carbocations with low-energy diradical states seems to be a promising one.  
BODIPY derivatives that release functional groups other than carboxylic acids and that have red-
shifted absorptions into the biological window (~600-1000 nm) are currently under investigation. 
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CHAPTER 4 
SHIFTING BODIPY PHOTOREMOVABLE GROUPS INTO THE RED 
Introduction 
Photoremovable protecting groups (also known as photocages, phototriggers, 
photoreleasable and photocleavable protecting groups) are light-sensitive moieties that allow 
for spatial and temporal control over the release of a masked substrate by light-induced 
cleavage of a covalent PPG-substrate bond resulting in the restoration the substrate’s function.  
Photocages are particularly useful for the release of biologically relevant substrates, such as 
proteins1-3, nucleotides4,5, ions6-10, neurotransmitters11-12, pharmaceuticals13-14, and fluorescent 
dyes15-17, and small molecules18,19.   
The most popular photocages used in biological studies are o-nitrobenzyl31,33 and 
derivatives, but others include those based on the phenacyl21, acridinyl22, benzoinyl23,24 
coumarinyl25, and o-hydroxynaphthyl26 structures.  A major limitation to many of these 
photocages and especially to the popular o-nitrobenzyl photocages is that they absorb in the 
ultraviolet region of the spectrum where tissue penetration is limited restricting studies for 
fixed cells and thin tissue slices.  In addition, exposure of the cells or tissues to UV light can 
lead to cellular damage or death. 
Recently, our lab developed a new class of protecting group derived from meso-
substituted BODIPY dyes with heterolytic bond cleavage occurring at green wavelengths >500 
nm.27  This BODIPY structure was first computationally explored to suggest it would undergo 
heterolytic bond cleavage in the excited29 and was then empirically investigated.   This is the 
first example of a rationally designed photocage releasing a cargo molecule using visible light 
making meso-substituted BODIPY dyes a promising alternative to the popular o-nitrobenzyl 
photocage systems.  A photocage which cleaves within the biological window of light would be 
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exceptionally valuable for cell and tissue studies.  The biological window identifies the range 
of wavelengths from 650 nm to 1130 nm where light can more efficiently penetrate biological 
tissue because these tissues scatter and absorb less light at longer wavelengths.28  
It has been well-established that extending the conjugation of BODIPY dyes allows for 
a red-shift in absorption maximum.30  Here we use a Knoevenagel condensation reaction to 
extend the conjugation on the highly-acidic 3,5-methyl groups of our previously synthesized 
BODIPY photocage structure.  
 
Figure 1. Knoevenagel condensation reaction was used to red shift the absorption maximum of 
BODIPY 2 from Chapter 3 
The following photocages were prepared: 
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Figure 2. BODIPY photocages with extended conjugation 
Results and Discussion 
To demonstrate that 1-4 could indeed release acetic acid during light irradiation, NMR 
was used to follow the release progress over time. 
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Figure 3. Release of acetic acid over time.  2 mM NMR samples were prepared and irradiated 
with a Xenon lamp.   
The thermal stability of the dyes was tested by heating to 60 oC for 1 hour in the dark.  
No acetic acid release was observed. 
 
Figure 4. Thermal stability test of 1-4; NMR scans were taken at room temperature (blue) and 
the samples were heated for one hour at 60oC and NMR scans were taken again (red); No acetic 
acid (2.04ppm) release was observed. The NMR spectrum has been cropped for clarity, 
however, there was no change in any NMR peaks after heating. 
The optical properties of 1-4 are shown in Fig. 5.  The absorption maxima of the 
compounds range from 586 nm to 661 nm and the fluorescence ranges from 607-684 nm.  
Photocages 2,3, and 4, absorb within the biological window of visible light making them 
powerful alternatives the o-nitrobenzyl photocage which absorbs in the UV.  The extinction 
coefficients of the photocages are ~60,000 M-1 cm-1.  The quantum yields are XXX, which are 
similar to the BODIPY dyes from Chapter 3.  These values are relatively low, however, the 
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high extinction coefficients of 1-4 make the quantum efficiencies similar to that of the popular 
o-nitrobenzyl photocages. 
 
 
Figure 5. Normalized absorption and fluorescence spectra of compounds 1-4  
 
Table 1. Absorption (λmax) and fluorescence (λem) maxima, extinction coefficients (ε), quantum 
yields (Ф) and quantum efficiencies (ε Ф) of compounds 1-4. 
 
 λmax (nm)  λem (nm)  ε (x 104 M-1 cm-1)  Ф (x 10-4)  ε Ф  
(M-1cm-1)  
1  586  607  6.1  9.8 6.0 
2  633  650  6.0  6.9 4.1 
3  640  656  6.5  4.5 2.9 
4  661  684 6.5  4.1 2.7 
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Work is currently underway to take 4 and replace the acetate leaving group with the 3,5 -
dinitrobenzoic acid fluorescence quencher as seen in Compound 7 from Chapter 3.  Similar 
biological studies within S2 cells are to be performed. 
Experimental 
8-Acetoxymethyl-1,3,5,7-tetramethyl pyrromethene fluoroborate was synthesized as previously 
reported. (Spectra for this compound matched those previously reported.) 
Synthesis of Compound 1. 8-Acetoxymethyl-1,3,5,7-tetramethyl pyrromethene fluoroborate (50 
mg, 0.016 mmol, 1 equivalent)  and 4-methoxybenzaldehyde (4.4 mg, 0.032 mmol, 2 equiv.) 
were added to 8 mL of ethanol which had been previously dried over 3 Å molecular sieves for 24 
h.  This suspension was then placed in a dry, glass microwave reaction vessel.  Both acetic acid 
(120 µL) and piperidine (120 µL) were then added and the vessel was sparged with argon. The 
microwave vessel was irradiated for 10 min at 113ᵒC and 800 W.  The solvent was evaporated 
under reduced pressure.  The solid residue was loaded onto a silica gel flash column and eluted 
with 50:50 hexanes:ethyl acetate.  The dark purple product was recovered and further purified 
using a prep TLC plate and 80:20 hexanes:ethyl acetate. The product was obtained in 58% yield 
(32 mg, 0.009 mmol). 1HNMR (400 MHz, CDCl3): δ = 7.55 (d, Ј = 4 Hz, 2H), 7.52 (d, J = 8 Hz, 
1H), 7.24 (d, J = 8 Hz, 1H), 6.91 (d, J = 4 Hz, 2H), 6.71 (s, 1H), 6.11 (s, 1H), 5.33 (s, 2H), 3.85 
(s, 3H), 2.58 (s, 3H), 2.43 (s, 3H), 2.28 (s, 3H), 2.15 (s, 3H) ppm; 13CNMR (200 MHz, CDCl3): 
δ = 170.77, 160.84, 155.56, 154.57, 141.15, 140.41, 137.32, 135.35, 134.46, 132.94, 131.39, 
129.37, 122.18, 118.87, 116.95, 114.45, 58.16, 55.24, 20.82, 16.05, 15.74, 14.94 ppm; Hi-res MS 
(ESI) for formula C24H25BF2N2O3, Calc. 438.2035, Found 438.2038.  
Synthesis of Compound 2. 8-Acetoxymethyl-1,3,5,7-tetramethyl pyrromethene fluoroborate (50 
mg, 0.016 mmol, 1 equiv)  and 4-(dimethylamino)benzaldehyde (4.8 mg, 0.032 mmol, 2 equiv) 
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were added to 8-mL of ethanol which had been previously dried over 3 Å molecular sieves for 
24 hours.  This suspension was then placed in a microwave reaction vessel.  Both acetic acid 
(120 µL) and piperidine (120 µL) were then added and the vessel was sparged with argon.  The 
microwave vessel was irradiated for 20 minutes at 113ᵒC and 800 W.  The solvent was 
evaporated under reduced pressure.  The solid residue was loaded onto a silica gel flash column 
and eluted with 80:20 hexanes:ethyl acetate to give 9.1 mg of 2 as a dark blue solid (24% yield).  
1HNMR (400 MHz, CDCl3): δ = 7.50 (d, J = 8Hz, 2H), 7.45 (d, J = 16 Hz, 1H), 7.24 (d, J = 16 
Hz, 1H), 6.72 (s, 1H), 6.68 (d, J = 8Hz, 2H), 6.07 (s, 1H), 5.32 (s, 2H), 3.04 (s, 6H), 2.57 (s, 3H), 
2.41 (s, 3H), 2.36 (s, 3H), 2.15 (s, 3H) ppm; 13CNMR (200 MHz, CDCl3): δ = 170.85, 156.07, 
153.42, 151.41, 141.39, 139.20, 138.64, 134.93, 132.28, 129.70, 124.56, 121.37, 119.21, 114.25, 
112.12, 58.31, 40.36, 24.02, 20.85, 16.12, 15.60 ppm; Hi-res MS (ESI) for formula 
C25H28BF2N3O2, Calc. 451.2352, Found 451.2339. 
Synthesis of Compound 3. 8-Acetoxymethyl-1,3,5,7-tetramethyl pyrromethene fluoroborate (50 
mg, 0.016 mmol, 1 equiv)  and benzaldehyde (3.4 mg, 0.032 mmol, 2 equiv) were added to 8 mL 
of ethanol which had been previously dried over 3 Å molecular sieves for 24 h.  This suspension 
was then placed in a microwave reaction vessel.  Both acetic acid (120 µL) and piperidine (120 
µL) were then added and the vessel was sparged with argon.  The microwave vessel was 
irradiated for 20 minutes at 113ᵒC and 800W.  The solvent was evaporated under reduced 
pressure.  The solid residue was loaded onto a silica gel flash column and eluted with 80:20 
hexanes:ethyl acetate to give 23.7 mg of 3 as a dark blue solid (38% yield). 1HNMR (400 MHz, 
CDCl3): δ = 7.71 (d, J = 8 Hz, 2H), 7.64, (d, J = 4 Hz, 4 H), 7.42 (t, J = 8 Hz, 4H), 7.34 (t, J = 8 
Hz, 2H), 7.30 (d, J = 8 Hz, 2H), 6.77 (s, 2H), 5.37 (s, 2H), 2.44 (s, 6H), 2.17 (s, 3H) ppm; 
13CNMR (200 MHz, CDCl3): δ = 170.62, 153.35, 140.42, 137.06, 136.43, 134.79, 130.23, 
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129.18, 128.82, 127.68, 118.94, 58.02, 22.71, 15.88, 14.14 ppm; Hi-res MS (ESI) for formula 
C30H27BF2N2O2Na
+, Calc. 519.2026, Found 519.2041. 
Synthesis of Compound 4. 8-Acetoxymethyl-1,3,5,7-tetramethyl pyrromethene fluoroborate (50 
mg, 0.016 mmol, 1 equivalent), 4-methoxybenzaldehyde (9.6 mg, 0.064 mmol, 4 equivalents) 
were added to a 10 mL Erlenmeyer flask. Dry toluene (3 mL) was added to the flask, followed 
by piperidine (1 mL).  The flask was heated until the toluene evaporated.  More toluene (1 mL) 
was then added and solvent allowed to evaporate again.  The solvent was completely evaporated 
under reduced pressure.  The solid residue was then loaded onto a silica gel flash column and 
eluted with 50:50 hexanes:ethyl acetate to give 4 as a dark blue solid.  The product was further 
purified using a prep TLC plate and 80:20 hexanes: ethyl acetate providing 17.8 mg of 4 (26% 
yield). 1HNMR (400 MHz, CDCl3): δ = 7.59 (d, J = 4Hz, 4H), 7.58 (d, J = 8 Hz, 2H), 7.24 (d, J 
= 8 Hz, 2H),  6.94 (d, J = 4 Hz, 4H), 6.73 (s, 2H), 5.35 (s, 2H), 3.87 (s, 6H), 2.43 (s, 6H), 2.16 (s, 
3H) ppm; 13CNMR (200 MHz, CDCl3): δ = 170.82, 160.73, 153.52, 140.06, 136.71, 134.73, 
129.58, 129.35, 118.76, 117.24, 114.46, 58.28, 55.54, 20.87, 15.99 ppm; Hi-res MS (ESI) for 
formula C32H31BF2N2O4, Calc. 556.2454, Found 556.2451. 
See Appendix IV for NMR and MS of compounds, stability tests, and product studies. 
Conclusions 
 Four new BODIPY based photocages were synthesized, 1-4.  They were found to 
successfully release acetic acid when irradiated with white light.  They were also found to be 
thermally stable for 1 hour at 60oC.  The optical properties of these photocages are outstanding 
with absorbances of 586 nm to 661 nm and extinction coefficients ~60,000 M-1 cm-1.  The 
quantum efficiencies were found to be XX which is on-par with the common 2-nitrobenzyl 
photocages making 1-4 potentially powerful alternatives.    Compounds 2,3, and 4 absorb within 
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the coveted biological window of light making them promising candidates for applications in 
cells and tissues.  Studies are currently underway to show the bio-compatibility of a BODIPY 
dye within S2 cells. 
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GENERAL CONCLUSIONS FOR PART 2 
 
BODIPY-derived photocages unmask carboxylic acids with green light excitation >500 
nm and photocleavage can be carried out in living cells.  These photocages are promising 
alternatives for the popular o-nitrobenzyl photocaging systems, being easy to synthesize, utilizing 
a biocompatible chromophore, and having superior optical properties to the most popular 
photocages in current use.  More generally, our strategy of identifying new photocages by 
searching for carbocations with low-energy diradical states seems to be a promising one. 
The BODIPY photocages’ absorbances are red-shifted into the “biological window” using 
a Knoevenagal condensation reaction.  These new photocages release acetic acid with red light 
excitiation >600 nm making them very promising for biological assays.  The red-shifted 
photocages were found to be thermally stable and have high extinction coefficients.  Studies are 
currently underway to show the bio-compatibility of a BODIPY dye within S2 cells and the release 
of different cargo bio-molecules. 
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APPENDIX I: SUPPLEMENTAL INFORMATION CHAPTER 1 
 
 
Stability Tests Compound 2 and 3  
 
 
 
 
 
 
 
 
 
 
 
 
Stability study of compound 2 (top) in water in the absence of a fluoride source.  The 
fluorescence brightness of 2 is so small that the water Raman band is seen.  No significant 
change in fluorescence intensity was observed over a 24 hour period. Similar results for 
compound 3 (bottom). 
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Product Studies Compound 2 and 3 
 
 
 
 
 
 
Product analysis of 2 and 3 after addition of fluoride confirms formation of phthalic acid and the 
free dye.  For 3, the free dye was confirmed by spiking the NMR sample with 3-(2-
benzothiazolyl)-7-hydroxycoumarin and observing the increase in the peaks labeled as free dye. 
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Appendix II: SUPPLEMENTAL INFORMATION CHAPTER 2 
 
Fluorescence Titration Procedure 
A stock solution (6.27 x 10-6 M) of 7-hydroxycoumarinyl 2-(nitrobenzyl) hydrogen phthalate 1 
was prepared in DMF.  These samples were irradiated with varying lengths of time.  The samples 
were then diluted with 1 mM phosphate buffered (pH = 7.0) water to 3.0 mL.  Excitation was 
carried out at 350 nm with all excitation and emission slit widths at 2 nm.  The titration was 
repeated three times, and the data were averaged.  The same experimental procedure was used in 
the titration of Compound 2 except it was titrated using 30% hydrogen peroxide aqueous 
solution. 
Compound Stability Tests  
 
7-
hydroxycoumarin
yl 2-(nitrobenzyl) 
hydrogen 
(Compound 1). 
Red line is initial 
scan and blue 
line is after 24 
hours. 
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Stability study of 7-hydroxycoumarinyl 2-(nitrobenzyl) hydrogen phthalate (top) and 7-
hydroxycoumarinyl 2-(4-hydroxymethyl)benzeneboronic phthalate (bottom) in water in the 
absence of light and hydrogen peroxide. The fluorescence intensity is so small that the water 
Raman band is seen at 397 nm. No significant change in fluorescence intensity was observed 
over a 24 hour period for Compound 1. A small increase in fluorescence was seen in Compound 
2 after a 16 hour period (red is initial scan and blue is after 16 hours), but insignificant compared 
to the increase in fluorescence intensity due to free dye. 
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Product Study Compound 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Product analysis of Compound 1 after exposure to light confirms formation of phthalic acid and 
the free dye.  
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APPENDIX III: SUPPLEMENTAL INFORMATION CHAPTER 3 
 
 
Acetic acid growth over time followed by NMR 
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The BODIPY compound was dissolved in minimum amount of CDCl3 to dissolve and then 
MeOD was added to it to make a 600 µl of 2 mM solution. A halogen lamp (500W) with a water 
IR cutoff filter was used to irradiate the sample and it was followed by NMR over time. Acetic 
acid release was plotted by relative integration ratio of caged to free acetic acid. 
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Preparative photolysis study of compound 2 
 
A 2 mM solution of compound 2 in a chloroform/methanol mixture was made and distributed 
evenly into multiple NMR test tubes and irradiated with a Xenon arc lamp.  The solutions were 
combined and concentrated under vacuum and redissolved in CDCl3. Photolysis progress was 
monitored by NMR until all starting compound 2 was gone. 1H NMR and mass spectrometry was 
used to confirm the formation of methyl ether adduct as the photolysis product. 
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APPENDIX IV: SUPPLEMENTAL INFORMATION CHAPTER 4 
 
The BODIPY compound was dissolved in minimum amount of CDCl3 to dissolve and then 
CD3OD was added to it to make a 600 µl of 2 mM solution. A Xenon arc lamp was used to 
irradiate the sample and it was followed by NMR over time.  
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Stability Tests Compounds 1-4 
 
1 mg of all compounds were dissolved in 20 µL of CD3OD and 600 µL of MeOD.  1 H NMR 
(600MHz) were recorded for these compounds at room temperature. They were then heated at 60 
°C in the dark for 1 hour. 1 H NMR was then retaken to compare with the earlier NMRs. 
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